SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change?

被引:0
|
作者
Alexander, James L. [1 ,2 ]
Powell, Nick [1 ,2 ]
机构
[1] Imperial Coll London, Dept Metab Digest & Reprod, London, England
[2] Imperial Coll Healthcare NHS Trust, Dept Gastroenterol, London, England
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:S28 / S29
页数:3
相关论文
共 50 条
  • [1] SARS-CoV-2 vaccination for patients with inflammatory bowel disease reply
    Alexander, James L.
    Kennedy, Nicholas A.
    Lees, Charlie W.
    Ahmad, Tariq
    Powell, Nick
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (07): : S23 - S24
  • [2] Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease
    Alexander, James L.
    Selinger, Christian P.
    Powell, Nick
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (12): : 987 - 988
  • [3] Bivalent mRNA SARS-CoV-2 vaccination in patients with inflammatory bowel disease
    Quan, Joshua
    Markovinovic, Ante
    Hracs, Lindsay
    Ma, Christopher
    Panaccione, Remo
    Kaplan, Gilaad G.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (12): : 1074 - 1075
  • [4] SARS-CoV-2 vaccination does not induce relapses of patients with inflammatory bowel disease
    Elkharsawi, Ahmed
    von Arnim, Ulrike
    Schmelz, Renate
    Sander, Cornelia
    Stallmach, Andreas
    Teich, Niels
    Walldorf, Jens
    Reuken, Philipp A.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, 60 (01): : 77 - 80
  • [5] SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy
    Selim, Rania
    Wellens, Judith
    Marlow, Luke
    Satsangi, Jack J.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (12): : 989 - 989
  • [6] SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease-Fear and Desire
    Walldorf, Jens
    von Arnim, Ulrike
    Schmelz, Renate
    Riesner-Wehner, Anica
    Michl, Patrick
    Grunert, Philip C.
    Stallmach, Andreas
    Teich, Niels
    Reuken, Philipp A.
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (11) : 1858 - 1861
  • [7] SARS-CoV-2 seroprevalence in patients with Inflammatory Bowel Disease
    Garcia Mateo, S.
    Martinez-Dominguez, S. J.
    Aso Gonzalvo, M. C.
    Gargallo-Puyuelo, C. J.
    Gallego Llera, B.
    Arroyo Villarino, M. T.
    Laredo de la Torre, V.
    Nocito Colon, M. M. L.
    Lario Quilez, L.
    Refaie, E.
    Latre Santos, M.
    Gomollon Garcia, F.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S564 - S564
  • [8] SARS-CoV-2 vaccination does not increase the risk for flares in Inflammatory Bowel Disease patients
    Rossier, L.
    Seibold, F.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 690 - 690
  • [9] Elevated Adherence to Vaccination Against SARS-CoV-2 Among Patients with Inflammatory Bowel Disease
    Giannini, Edoardo G.
    Demarzo, Maria Giulia
    Bodini, Giorgia
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (12): : 2142 - 2143
  • [10] Cellular and Humoral Immune Responses to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease Patients
    Cerna, Karin
    Duricova, Dana
    Hindos, Miroslav
    Hindos, Hrebackova Jana
    Lukas, Martin
    Machkova, Nadezda
    Hruba, Veronika
    Mitrova, Katarina
    Kubickova, Kristyna
    Kastylova, Kristyna
    Teplan, Vladimir
    Lukas, Milan
    JOURNAL OF CROHNS & COLITIS, 2022, 16 (09): : 1347 - 1353